Share this Post!

The Food and Drug Administration (FDA) warns all healthcare professionals and establishments on the voluntary recall of affected lots of Medtronic Valiant Naviation Thoracic Stent Graft System with FDA registration numbers, MDR-10572A, manufactured by Medtronic Inc., imported and distributed by Medtronic Philippines, Inc.:

Product Name Model #/ CFN Product Name Model #/ CFN
Stent Graft VNMC2020C94TE Stent Graft VNMC4646C95TU
VNMC2020C94TJ VNMF2020C96TE
VNMC2020C94TU VNMF2020C96TU
VNMC2222C180TE VNMF2222C185TE
VNMC2222C180TJ VNMF2222C185TU
VNMC2222C180TU VNMF2222C96TE
VNMC2222C94TE VNMF2222C96TJ
VNMC2222C94TJ VNMF2222C96TU
VNMC2222C94TU VNMF2520C185TE
VNMC2520C186TE VNMF2520C185TJ
VNMC2520C186TJ VNMF2520C185TU
VNMC2520C186TU VNMF2525C185TE
VNMC2525C180TE VNMF2525C185TJ
VNMC2525C180TJ VNMF2525C185TU
VNMC2525C180TU VNMF2525C96TE
VNMC2525C94TE VNMF2525C96TJ
VNMC2525C94TJ VNMF2525C96TU
VNMC2525C94TU VNMF2822C173TE
VNMC2822C207TE VNMF2822C173TJ
VNMC2822C207TJ VNMF2822C173TU
VNMC2822C207TU VNMF2828C174TE
VNMC2828C182TE VNMF2828C174TJ
VNMC2828C182TJ VNMF2828C174TU
VNMC2828C182TU VNMF2828C97TE
VNMC2828C90TE VNMF2828C97TJ
VNMC2828C90TJ VNMF2828C97TU
VNMC2828C90TU VNMF3125C173TE
Stent Graft VNMC3125C207TE Stent Graft VNMF3125C173TJ
VNMC3125C207TJ VNMF3125C173TU
VNMC3125C207TU VNMF3131C174TE
VNMC3131C182TE VNMF3131C174TJ
VNMC3131C182TJ VNMF3131C174TU
VNMC3131C182TU VNMF3131C229TE
VNMC3131C223TE VNMF3131C229TJ
VNMC3131C223TJ VNMF3131C229TU
VNMC3131C223TU VNMF3131C97TE
VNMC3131C90TE VNMF3131C97TJ
VNMC3131C90TJ VNMF3131C97TU
VNMC3131C90TU VNMF3428C173TE
VNMC3428C207TE VNMF3428C173TJ
VNMC3428C207TJ VNMF3428C173TU
VNMC3428C207TU VNMF3434C174TE
VNMC3434C182TE VNMF3434C174TJ
VNMC3434C182TJ VNMF3434C174TU
VNMC3434C182TU VNMF3434C229TE
VNMC3434C223TE VNMF3434C229TJ
VNMC3434C223TJ VNMF3434C229TU
VNMC3434C223TU VNMF3434C59TE
VNMC3434C52TE VNMF3434C59TJ
VNMC3434C52TJ VNMF3434C59TU
VNMC3434C52TU VNMF3434C97TE
VNMC3434C90TE VNMF3434C97TJ
VNMC3434C90TJ VNMF3434C97TU
VNMC3434C90TU VNMF3731C173TE
VNMC3731C207TE VNMF3731C173TJ
VNMC3731C207TJ VNMF3731C173TU
VNMC3731C207TU VNMF3737C174TE
VNMC3737C182TE VNMF3737C174TJ
VNMC3737C182TJ VNMF3737C174TU
VNMC3737C182TU VNMF3737C229TE
VNMC3737C223TE VNMF3737C229TJ
VNMC3737C223TJ VNMF3737C229TU
VNMC3737C223TU VNMF3737C59TE
VNMC3737C52TE VNMF3737C59TJ
VNMC3737C52TJ VNMF3737C59TU
VNMC3737C52 VNMF3737C97TE
VNMC3737C90TE VNMF3737C97TJ
VNMC3737C90TJ VNMF3737C97TU
VNMC3737C90TU VNMF4034C185TE
VNMC4034C200TE VNMF4034C185TJ
VNMC4034C200TJ VNMF4034C185TU
VNMC4034C200TU VNMF4040C103TE
VNMC4040C175TE VNMF4040C103TJ
VNMC4040C175TJ VNMF4040C103TU
VNMC4040C175TU VNMF4040C183TE
VNMC4040C218TE VNMF4040C183TJ
Stent Graft VNMC4040C218TJ Stent Graft VNMF4040C183TU
VNMC4040C218TU VNMF4040C223TE
VNMC4040C55TE VNMF4040C223TJ
VNMC4040C55TJ VNMF4040C223TU
VNMC4040C55TU VNMF4040C62TE
VNMC4040C95TE VNMF4040C62TJ
VNMC4040C95TJ VNMF4040C62TU
VNMC4040C95TU VNMF4337C185TE
VNMC4337C200TE VNMF4337C185TJ
VNMC4337C200TJ VNMF4337C185TU
VNMC4337C200TU VNMF4343C103TE
VNMC4343C175TE VNMF4343C103TJ
VNMC4343C175TJ VNMF4343C103TU
VNMC4343C175TU VNMF4343C183TE
VNMC4343C218TE VNMF4343C183TJ
VNMC4343C218TJ VNMF4343C183TU
VNMC4343C218TU VNMF4343C223TE
VNMC4343C55TE VNMF4343C223TJ
VNMC4343C55TJ VNMF4343C223TU
VNMC4343C55TU VNMF4343C62TE
VNMC4343C95TE VNMF4343C62TJ
VNMC4343C95TJ VNMF4343C62TU
VNMC4343C95TU VNMF4640C185TE
VNMC4640C200TE VNMF4640C185TJ
VNMC4640C200TJ VNMF4640C185TU
VNMC4640C200TU VNMF4646C103TE
VNMC4646C175TE VNMF4646C103TJ
VNMC4646C175TJ VNMF4646C103TU
VNMC4646C175TU VNMF4646C183TE
VNMC4646C218TE VNMF4646C183TJ
VNMC4646C218TJ VNMF4646C183TU
VNMC4646C218TU VNMF4646C223TE
VNMC4646C55TE VNMF4646C223TJ
VNMC4646C55TJ VNMF4646C223TU
VNMC4646C55TU VNMF4646C62TE
VNMC4646C95TE VNMF4646C62TJ
VNMC4646C95TJ VNMF4646C62TU

Medtronic International, Ltd. initiated the voluntary recall of the above-mentioned specific lots/batches of Medtronic Valiant Naviation Thoracic Stent Graft System. The recall is being initiated in response to information identified in the Valiant Evo Global Clinical Program, which studied the performance of the above-mentioned product. A total of 110 subjects were enrolled in the Valiant Evo Global Clinical Program. The information received indicated that there were three (3) subjects with stent fractures of which (2) confirmed Type IIIb endoleaks, and seven (7) core lab analysis findings showing stent ring enlargement. Type IIIb endoleaks, if untreated, can potentially lead to aneurysm rupture.                

In light of the foregoing, all concerned healthcare professional, establishments, and the general public are warned to discontinue further use, sale, and distribution of the said affected lots/batches of Medtronic Valiant Naviation Thoracic Stent Graft System.

All FDA Regional Field Offices and Regulatory Enforcement Units, in coordination with law enforcement agencies and Local Government Units, are requested to ensure that product is not sold or made available in the market or areas of jurisdiction.

Any suspected adverse reaction experienced from the use of the medical device but not limited to the lot numbers stated above should be reported immediately to FDA.

For more information and inquiries, kindly contact the FDA Center for Device Regulation, Radiation Health, and Research through e-mail at [email protected], or call (02) 8857-1900 loc. 8301

Dissemination of this advisory to all concerned is hereby requested.

Attachments